LEXX logo

Lexaria Bioscience (LEXX) Company Overview

Profile

Full Name:

Lexaria Bioscience Corp.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Canada

IPO:

January 12, 2021

Indexes:

Not included

Description:

Lexaria Bioscience is a biotechnology company focused on improving the delivery of active pharmaceutical ingredients using its unique technology. They aim to enhance the absorption of cannabinoids and other compounds, making them more effective for health and wellness products. Their innovations target better taste and faster effects.

Key Details

Price

$1.39

Annual Revenue

$464.30 K(+105.26% YoY)

Annual EPS

-$0.47(+53.47% YoY)

Annual ROE

-112.11%

Beta

0.63

Events Calendar

Earnings

Next earnings date:

Apr 9, 2025

Recent quarterly earnings:

Jan 10, 2025

Recent annual earnings:

Nov 29, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 12, 2021

Analyst ratings

Recent major analysts updates

Jan 24, 25 HC Wainwright & Co.
Buy
Dec 2, 24 HC Wainwright & Co.
Buy
Nov 25, 24 HC Wainwright & Co.
Buy
Jul 18, 24 HC Wainwright & Co.
Buy
Jul 10, 24 HC Wainwright & Co.
Buy
Mar 5, 24 Maxim Group
Buy
Jul 21, 23 Maxim Group
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Lexaria Bioscience?
  • Does Lexaria Bioscience pay dividends?
  • What sector is Lexaria Bioscience in?
  • What industry is Lexaria Bioscience in?
  • What country is Lexaria Bioscience based in?
  • When did Lexaria Bioscience go public?
  • Is Lexaria Bioscience in the S&P 500?
  • Is Lexaria Bioscience in the NASDAQ 100?
  • Is Lexaria Bioscience in the Dow Jones?
  • When was Lexaria Bioscience's last earnings report?
  • When does Lexaria Bioscience report earnings?
  • Should I buy Lexaria Bioscience stock now?

What is the ticker symbol for Lexaria Bioscience?

The ticker symbol for Lexaria Bioscience is NASDAQ:LEXX

Does Lexaria Bioscience pay dividends?

No, Lexaria Bioscience does not pay dividends

What sector is Lexaria Bioscience in?

Lexaria Bioscience is in the Healthcare sector

What industry is Lexaria Bioscience in?

Lexaria Bioscience is in the Biotechnology industry

What country is Lexaria Bioscience based in?

Lexaria Bioscience is headquartered in Canada

When did Lexaria Bioscience go public?

Lexaria Bioscience's initial public offering (IPO) was on January 12, 2021

Is Lexaria Bioscience in the S&P 500?

No, Lexaria Bioscience is not included in the S&P 500 index

Is Lexaria Bioscience in the NASDAQ 100?

No, Lexaria Bioscience is not included in the NASDAQ 100 index

Is Lexaria Bioscience in the Dow Jones?

No, Lexaria Bioscience is not included in the Dow Jones index

When was Lexaria Bioscience's last earnings report?

Lexaria Bioscience's most recent earnings report was on Jan 10, 2025

When does Lexaria Bioscience report earnings?

The next expected earnings date for Lexaria Bioscience is Apr 9, 2025

Should I buy Lexaria Bioscience stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions